Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BID | P55957 | 3/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.47 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.47 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.47 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.47 |
| ▸ | SAE1 | Q9UBE0 | 2/20 | 0.47 |
| ▸ | PPARA | Q07869 | 2/20 | 0.47 |
| ▸ | PPARG | P37231 | 1/20 | 0.47 |
| ▸ | EP300 | Q09472 | 1/20 | 0.47 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.47 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.47 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.47 |
| ▸ | PTGER4 | P35408 | 3/20 | 0.46 |
| ▸ | PTGER3 | P43115 | 3/20 | 0.46 |
| ▸ | PTGER2 | P43116 | 3/20 | 0.46 |
| ▸ | MMP2 | P08253 | 2/20 | 0.44 |
| ▸ | F7 | P08709 | 2/20 | 0.44 |
| ▸ | F3 | P13726 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20424548 | 0.90 | PTGER3 (0.47) | PTGER4PTGER3PTGER2HSD17B10 | |
| SCHEMBL16339260 | 0.90 | PTGER3 (0.55) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL16339259 | 0.90 | PTGER3 (0.55) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL6437827 | 0.88 | PTGER3 (0.54) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL3684323 | 0.88 | PTGER3 (0.54) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL291771 | 0.88 | PTGER3 (0.54) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL2356096 | 0.88 | PTGER3 (0.54) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL3250731 | 0.88 | PTGER3 (0.54) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL489896 | 0.88 | PTGER3 (0.54) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL8702148 | 0.85 | PTGER3 (0.56) | BIDMCL1BCL2L1BAK1KAT8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11382848-B2 | Compounds reducing malodour perception and the use thereof | CHEMCOM S.A. (BE) | 2022-07-12 | — | — | US | disclosed |
| EP-3573944-B1 | COMPOUNDS REDUCING MALODOUR PERCEPTION AND THE USE THEREOF | CHEMCOM SA (BE) | 2022-03-02 | — | — | EP | disclosed |
| WO-2018138369-A1 | COMPOUNDS REDUCING MALODOUR PERCEPTION AND THE USE THEREOF | CHEMCOM S.A. (BE) | 2018-08-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11382848-B2 | Compounds reducing malodour perception and the use thereof | OR51E2, OR10J3, SRD5A1 | BID 1197/4885MCL1 4850/4885BCL2L1 3510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.